This is a working overview of IGF-1, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-12 and is reviewed periodically as new material appears.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
America's Taco Shop – a restaurant chain with locations only in Arizona. Baja Fresh – a chain of fast-casual Tex Mex restaurants in the United States, Portugal and Kuwait. Blimpie – an American submarine sandwich chain with locations in the United States and Kuwait Cereality – a chain with stores in Texas, West Virginia, Minnesota and Ohio; also formerly had stores in Illinois. Cold Stone Creamery – an ice cream parlor restaurant chain with stores in Bahrain, Canada (partnership with Burger King/Tim Hortons from 2008 to 2014 now terminated), China, Denmark, Egypt, India, Indonesia, Japan, Kuwait, Mexico, Nigeria, Oman, Qatar, South Korea, Taiwan, United Arab Emirates, United States, Philippines, Kenya, Bangladesh, Pakistan, Finland, Jordan, Norway, Saudi Arabia, Sweden, Vietnam, Singapore and Lebanon Frullati Cafe & Bakery – chain with stores in Kuwait and the United States. Grabbagreen – a chain of restaurants offering healthy foods and smoothies. Great Steak – a restaurant chain with locations in Canada, Mexico, Kuwait and the United States. Founded 1982; formerly "Great Steak & Potato Company". In 2000, it had 225 locations. Sold to Kahala Brands in 2004; expansion planned into South Korea. Johnnie's New York Pizzeria – restaurant chain with stores in California, Florida, Oregon, and Texas. Kahala Coffee Traders (California, Utah) La Salsa – a chain of fast-casual Tex Mex restaurants in the United States Maui Wowi Hawaiian – chain with stores in the United States, Mexico, Saudi Arabia and the United Arab Emirates.
Dean Robinson (born 9 September 1974) is an Australian fitness coach who has worked with a variety of both AFL and NRL clubs. Better known as The Weapon, Robinson is notable for his intense training methods which were criticised following a spate of soft-tissue injuries at Essendon in the second half of the 2012 AFL season. Prior to his work as a professional fitness coach, Robinson showed a passion for rodeo. Acting the position of both a steer wrestler and a rodeo clown, Robinson proved a versatile competitor and went all the way to the World Steer Wrestling Association titles in 1997. He also spent several years training other rodeo athletes, before later branching out into additional sports. Before his association with a long string of clubs, Robinson worked at the NSW Institute of Sport. His subsequent transition into the NRL was sparked by his brother Trent Robinson, who had been employed in a variety of coaching roles at several clubs. Beginning in 2005, Robinson worked with the Manly Sea Eagles. Spending two years at the club, Robinson implemented a far more scientific approach to training than was previously in place. Robinson’s contribution to the club’s improved performance did not go unnoticed, and in 2006 AFL clubs also began to express interest in his services. This soon culminated in the Geelong Football Club hiring him for the 2007 season. Robinson left Geelong to join the new Gold Coast Football Club in their inaugural season. After a year there, he moved back to Melbourne and began working for the Essendon Football Club.
=== Pharmacokinetics === Dupilumab shows a non-linear rate in regard to the target. Dupilumab is also reported to have a bioavailability of 64%, with the average concentration occurring one week after injection.
The New York term hero is first attested in 1937. The name is sometimes credited to the New York Herald Tribune food writer Clementine Paddleford in the 1930s, but there is no good evidence for the claim. It is also sometimes said that it is related to the gyro; that is unlikely as the gyro was unknown in the United States until the 1960s. Hero (plural usually heros not heroes) remains the prevailing New York City term for most sandwiches on an oblong roll with a generally Italian flavor, in addition to the original described above. Pizzeria menus often include eggplant parmigiana, chicken parmigiana, and meatball heros, each served with sauce.
Sources: en.wikipedia.org
=== Cultivation === White-barked birches in particular are cultivated as ornamental trees, largely for their appearance in winter. The Himalayan birch, Betula utilis, especially the variety or subspecies jacquemontii, is among the most widely planted for this purpose. It has been cultivated since the 1870s, and many cultivars are available, including 'Doorenbos', 'Grayswood Ghost' and 'Silver Shadow'; 'Knightshayes' has a slightly weeping habit. Other species with ornamental white bark include Betula ermanii, Betula papyrifera, Betula pendula and Betula raddeana.
The 2007 research showed that the influenza virus was still active on stainless steel 24 hours after contamination. Though on hands it survives only for five minutes, the constant contact with a fomite almost certainly means catching the infection. Transfer efficiency depends not only on surface, but mainly on pathogen type. For example, avian influenza survives on both porous and non-porous materials for 144 hours. Smallpox was long supposed to be transmitted either by direct contact or by fomites. However A. R. Rao’s careful researches in the 1960s, before smallpox was declared extinct, found little truth in the traditional belief that smallpox can be spread at a distance through infected clothing or bedding. He concluded that it normally invaded via the lungs. Rao recognized that the virus can be detected on inanimate objects, and therefore might in some cases be transmitted by them, but he concluded that “smallpox is still an inhalation disease ... the virus has to enter through the nose by inhalation". In 2002 Donald K. Milton published a review of existing research upon the transmission of smallpox and upon recommendations for controlling its spread in the event of its use in biological war. He agreed, citing Rao, Fenner and others, that “careful epidemiologic investigation rarely implicated fomites as a source of infection”; and broadly agreed with current recommendations for control of secondary smallpox infections, which emphasized transmission via “expelled droplets” upon the breath.
Powdered alcohol is made by a process called micro-encapsulation. An auxiliary material for a capsule may be any readily water-soluble substance (e.g. carbohydrate such as dextrins (starch hydrolyzate), protein such as gelatin). For powdered alcohol, maltodextrin (a type of dextrin) was chosen. For the process to encapsulate, a method called spray drying was selected. In this process, a mixture of dextrin and the alcoholic drink is subjected to simultaneous spraying and heating. The spraying converts the liquid to small drops (up to several hundred μm (micrometers) in diameter), and the heat causes the hydrous dextrin to form a film. When the film dries, the drop becomes a microcapsule containing a dehydrated alcoholic drink and dextrin. Drying removes about 90% of the water and 10% of the ethanol from the initial liquid. An explanation for this preferential loss of water over volatile organics like ethanol is called "selective diffusion": a carbohydrate (in this case, maltodextrin) film forms during spray-drying on each droplet. The film allows smaller molecules like water to go through, but not larger ones like ethanol. As a result, more water is lost. The film is formed in about 0.1 second from the creation of the droplet by spraying. There is no time for the internal convection in each drop or capsule to occur. The end result of spray-drying is large amounts of microcapsules with the appearance of a powder. This is powdered alcohol. According to Sato's web page, powdered alcohol contains 30.5% ethyl alcohol by volume in the state of powder.
But almost everywhere, in one form or another, there was the concept of a "philosopher's stone" – some substance that is able to turn other metals into gold, and when taken internally in small doses, heal all diseases, rejuvenate an old body and even give biological immortality. Alternatively, there were attempts to prepare "pills of immortality". During centuries alchemy gradually transformed to chemistry, in parallel giving birth to many adjacent sciences or enriching them. It is worth noticing the direction of iatrochemistry – a rational direction of alchemy with the main goal of preparing medicinal products. The pioneers of iatrochemistry were Paracelsus (1493–1541), Jan Baptist van Helmont (1580–1644) and Franciscus Sylvius (1614–1672). The converging field of alchemy was transformed into pharmacy. 1513 — searching for the Fountain of Youth is in popular culture thought to be one of the purposes of the expedition of the Spanish conquistador Juan Ponce de León, which lead to the discovery of Florida – however, there is no contemporary evidence of this, and this purpose is considered a myth by historians. 1550 — a Venetian nobleman Luigi Cornaro published the book The Art of Living Long, describing the style of life for the achievement of longevity. The book was translated into many languages. The English version of the book till the 19th century went through more than 50 editions. The main idea of the book: in order to live many years, you need to live in moderation, eat simply and little.
== Forensic detection == Worldwide, certain traditional Chinese medicines contain wild bear bile, banned under CITES legislation. Dip sticks, similar to common pregnancy tests, have been developed to detect the presence of bear albumin in traditional medicine products, indicating that bear bile had been used in their creation.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.